Dementia with Lewy Bodies (DLB), Parkinson’s Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1)
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2025-06-01
|
| Series: | ACS Omega |
| Online Access: | https://doi.org/10.1021/acsomega.4c10959 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849690036622065664 |
|---|---|
| author | Francesco Angelucci Zuzana Nedelska Blanka Napravnikova Manová Alžbeta Katonová Vanesa Jurášová Daniela Svetlikova Martin Vyhnálek Jakub Hort |
| author_facet | Francesco Angelucci Zuzana Nedelska Blanka Napravnikova Manová Alžbeta Katonová Vanesa Jurášová Daniela Svetlikova Martin Vyhnálek Jakub Hort |
| author_sort | Francesco Angelucci |
| collection | DOAJ |
| format | Article |
| id | doaj-art-d8b5a5e10aa940af9b32968ef2ef2cf8 |
| institution | DOAJ |
| issn | 2470-1343 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | American Chemical Society |
| record_format | Article |
| series | ACS Omega |
| spelling | doaj-art-d8b5a5e10aa940af9b32968ef2ef2cf82025-08-20T03:21:26ZengAmerican Chemical SocietyACS Omega2470-13432025-06-011023241942419910.1021/acsomega.4c10959Dementia with Lewy Bodies (DLB), Parkinson’s Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1)Francesco Angelucci0Zuzana Nedelska1Blanka Napravnikova Manová2Alžbeta Katonová3Vanesa Jurášová4Daniela Svetlikova5Martin Vyhnálek6Jakub Hort7Memory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech RepublicMemory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech RepublicMemory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech RepublicMemory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech RepublicMemory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech RepublicMemory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech RepublicMemory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech RepublicMemory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republichttps://doi.org/10.1021/acsomega.4c10959 |
| spellingShingle | Francesco Angelucci Zuzana Nedelska Blanka Napravnikova Manová Alžbeta Katonová Vanesa Jurášová Daniela Svetlikova Martin Vyhnálek Jakub Hort Dementia with Lewy Bodies (DLB), Parkinson’s Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1) ACS Omega |
| title | Dementia with Lewy Bodies (DLB), Parkinson’s Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1) |
| title_full | Dementia with Lewy Bodies (DLB), Parkinson’s Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1) |
| title_fullStr | Dementia with Lewy Bodies (DLB), Parkinson’s Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1) |
| title_full_unstemmed | Dementia with Lewy Bodies (DLB), Parkinson’s Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1) |
| title_short | Dementia with Lewy Bodies (DLB), Parkinson’s Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1) |
| title_sort | dementia with lewy bodies dlb parkinson s disease pd and multiple system atrophy msa are synucleopathies characterized by increased serum levels of plasminogen activator inhibitor 1 pai 1 |
| url | https://doi.org/10.1021/acsomega.4c10959 |
| work_keys_str_mv | AT francescoangelucci dementiawithlewybodiesdlbparkinsonsdiseasepdandmultiplesystematrophymsaaresynucleopathiescharacterizedbyincreasedserumlevelsofplasminogenactivatorinhibitor1pai1 AT zuzananedelska dementiawithlewybodiesdlbparkinsonsdiseasepdandmultiplesystematrophymsaaresynucleopathiescharacterizedbyincreasedserumlevelsofplasminogenactivatorinhibitor1pai1 AT blankanapravnikovamanova dementiawithlewybodiesdlbparkinsonsdiseasepdandmultiplesystematrophymsaaresynucleopathiescharacterizedbyincreasedserumlevelsofplasminogenactivatorinhibitor1pai1 AT alzbetakatonova dementiawithlewybodiesdlbparkinsonsdiseasepdandmultiplesystematrophymsaaresynucleopathiescharacterizedbyincreasedserumlevelsofplasminogenactivatorinhibitor1pai1 AT vanesajurasova dementiawithlewybodiesdlbparkinsonsdiseasepdandmultiplesystematrophymsaaresynucleopathiescharacterizedbyincreasedserumlevelsofplasminogenactivatorinhibitor1pai1 AT danielasvetlikova dementiawithlewybodiesdlbparkinsonsdiseasepdandmultiplesystematrophymsaaresynucleopathiescharacterizedbyincreasedserumlevelsofplasminogenactivatorinhibitor1pai1 AT martinvyhnalek dementiawithlewybodiesdlbparkinsonsdiseasepdandmultiplesystematrophymsaaresynucleopathiescharacterizedbyincreasedserumlevelsofplasminogenactivatorinhibitor1pai1 AT jakubhort dementiawithlewybodiesdlbparkinsonsdiseasepdandmultiplesystematrophymsaaresynucleopathiescharacterizedbyincreasedserumlevelsofplasminogenactivatorinhibitor1pai1 |